Business Description
SymBio Pharmaceuticals Ltd
ISIN : US87150Y1001
Share Class Description:
SYMQY: ADRDescription
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in manufacturing and commercializing drugs for oncology, hematology, and pain management.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.91 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.24 | |||||
Beneish M-Score | -4.42 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.6 | |||||
3-Year EBITDA Growth Rate | 49 | |||||
3-Year EPS without NRI Growth Rate | 33.3 | |||||
3-Year FCF Growth Rate | 56.4 | |||||
3-Year Book Growth Rate | 11.9 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -28.82 | |||||
12-1 Month Momentum % | -58.56 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.68 | |||||
Quick Ratio | 10.43 | |||||
Cash Ratio | 9.16 | |||||
Days Inventory | 126.08 | |||||
Days Sales Outstanding | 74.51 | |||||
Days Payable | 20.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.4 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.38 | |||||
Operating Margin % | -35.96 | |||||
Net Margin % | -59.12 | |||||
FCF Margin % | -9.26 | |||||
ROE % | -35.37 | |||||
ROA % | -31.99 | |||||
ROIC % | -139 | |||||
ROC (Joel Greenblatt) % | -148.71 | |||||
ROCE % | -21.51 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.02 | |||||
PB Ratio | 1.47 | |||||
Price-to-Tangible-Book | 1.48 | |||||
EV-to-EBIT | -2.39 | |||||
EV-to-EBITDA | -2.39 | |||||
EV-to-Forward-EBITDA | 11.12 | |||||
EV-to-Revenue | 0.86 | |||||
EV-to-Forward-Revenue | 2 | |||||
EV-to-FCF | -9.33 | |||||
Price-to-Median-PS-Value | 0.55 | |||||
Price-to-Net-Current-Asset-Value | 1.49 | |||||
Price-to-Net-Cash | 1.75 | |||||
Earnings Yield (Greenblatt) % | -41.84 | |||||
FCF Yield % | -4.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SYMQY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SymBio Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 32.069 | ||
EPS (TTM) ($) | -0.459 | ||
Beta | 0.18 | ||
Volatility % | 48.35 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.000025 | ||
20-Day SMA ($) | 1.21 | ||
12-1 Month Momentum % | -58.56 | ||
52-Week Range ($) | 1.21 - 2.92 | ||
Shares Outstanding (Mil) | 45.81 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SymBio Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SymBio Pharmaceuticals Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
SymBio Pharmaceuticals Ltd Frequently Asked Questions
What is SymBio Pharmaceuticals Ltd(SYMQY)'s stock price today?
The current price of SYMQY is $1.21. The 52 week high of SYMQY is $2.92 and 52 week low is $1.21.
When is next earnings date of SymBio Pharmaceuticals Ltd(SYMQY)?
The next earnings date of SymBio Pharmaceuticals Ltd(SYMQY) is .
Does SymBio Pharmaceuticals Ltd(SYMQY) pay dividends? If so, how much?
SymBio Pharmaceuticals Ltd(SYMQY) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |